What is Nurix Therapeutics, Inc.'s revenue?

Nurix Therapeutics, Inc. (NRIX) reported revenue of $6.25M in Q4 2025.

How has Nurix Therapeutics, Inc.'s revenue changed year-over-year?

Nurix Therapeutics, Inc.'s revenue decreased by 66.1% year-over-year, from $18.45M to $6.25M.

What is the long-term trend for Nurix Therapeutics, Inc.'s revenue?

Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s revenue has grown at a 29.5% compound annual growth rate (CAGR), from $38.63M to $83.98M.

Nurix Therapeutics, Inc. NRIX Revenue

Revenue at other companies

HTF

Heartflow, Inc. Common StockHTFL

$52.59M+41.3%

Cal-Maine FoodsCALM

$666.95M-53.0%

DJT

Trump Media & Technology GroupDJT

$871.2K+6.1%

ADMA BiologicsADMA

$114.49M-0.3%

Minerals TechnologiesMTX

$546.9M+11.2%

Lincoln Educational Services CorporationLINC

$143.96M+22.5%

Other financials

Income statement

See full

Revenue$6.3M-66.1%

Operating income-$92.5M-47.1%

Net income-$87.2M-54.7%

EPS (diluted)-$0.79-17.9%

Balance sheet

See full

Cash & equivalents$72.2M-6.1%

Total debt$58.7M+120%

Total equity$480.9M0.0%

Total assets$636.1M+3.4%

Cash flow

See full

Operating cash flow-$71.9M-17.7%

CapEx$1.0M-70.0%

Free cash flow-$73.0M-13.0%

Valuation

See full

Market cap$2B+40.1%

Profitability

See full

Operating margin-439.3%+35.3pp

Net margin-411.4%+52.7pp

FCF margin-378.7%+24.1pp

Returns & leverage

See full

Return on equity-61.4%-2.5pp

Debt / equity0.1×+0.1×

Current ratio6×-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s revenue?: Nurix Therapeutics, Inc. (NRIX) reported revenue of $6.25M in Q4 2025.
How has Nurix Therapeutics, Inc.'s revenue changed year-over-year?: Nurix Therapeutics, Inc.'s revenue decreased by 66.1% year-over-year, from $18.45M to $6.25M.
What is the long-term trend for Nurix Therapeutics, Inc.'s revenue?: Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s revenue has grown at a 29.5% compound annual growth rate (CAGR), from $38.63M to $83.98M.